Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Catalysts Filings Track record Movers The Lead Compound

Home › Targets › IL-6/JAK1

IL-6/JAK1 (1 companies · 1 programs)

Companies with an active program directed at IL-6/JAK1.

EyePoint, Inc. EYPT

DURAVYU — Diabetic Macular Edema Phase 3

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.